|
Volumn 17, Issue 5, 2003, Pages 604-605
|
Low-molecular-weight heparin (enoxaparin) in the treatment of lichen planus [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHISTAMINIC AGENT;
CORTICOSTEROID;
ENOXAPARIN;
HEPARAN SULFATE;
HEPARIN;
HEPARIN DERIVATIVE;
LOW MOLECULAR WEIGHT HEPARIN;
SEDATIVE AGENT;
ADOLESCENT;
ADULT;
BLOOD CHEMISTRY;
BLOOD CLOTTING TEST;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LABORATORY TEST;
LETTER;
LICHEN PLANUS;
MALE;
PRIORITY JOURNAL;
PRURITUS;
PUVA;
RECURRENT DISEASE;
SIDE EFFECT;
SKIN BIOPSY;
ANIMALS;
CLINICAL TRIALS;
DISEASE MODELS, ANIMAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
ENOXAPARIN;
FIBRINOLYTIC AGENTS;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
LICHEN PLANUS;
MICE;
PROGNOSIS;
TREATMENT OUTCOME;
|
EID: 0141762655
PISSN: 09269959
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1468-3083.2003.00732.x Document Type: Letter |
Times cited : (13)
|
References (6)
|